找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Clinical Management of Renal Tumors; Ronald M. Bukowski,Andrew C. Novick Book 2008 The Editor(s) (if applicable) and The Author(s), under

[復(fù)制鏈接]
樓主: POL
51#
發(fā)表于 2025-3-30 11:57:41 | 只看該作者
52#
發(fā)表于 2025-3-30 15:03:33 | 只看該作者
53#
發(fā)表于 2025-3-30 16:47:15 | 只看該作者
The Role of Angioinfarction in the Management of Renal Tumors,ogenesis pathways by eliminating the tumor’s blood supply. Angioinfarction of renal tumors may be used to both the surgeon’s and patient’s advantage. Here we review the history, indications, techniques, and complications of angioinfarction in the management of primary renal tumors and their metastas
54#
發(fā)表于 2025-3-30 23:24:51 | 只看該作者
Surveillance Strategies Following Curative Therapy for Localized Renal Cell Carcinoma,lly recurrent and metastatic disease. Assuming that success of clinical intervention at the time of relapse is inversely proportional to the disease burden at the time of salvage treatment, ideal surveillance protocol should allow the earliest identification of potentially treatable recurrences whil
55#
發(fā)表于 2025-3-31 01:18:00 | 只看該作者
Local Recurrence of Renal Cell Carcinoma: ,,l encapsulated. Local recurrence presents unique challenges. This chapter reviews the incidence, risk factors, and management of local recurrence for patients with RCC. Local recurrence occurs primarily as ipsilateral recurrence in the renal fossa after radical nephrectomy and within the residual pa
56#
發(fā)表于 2025-3-31 05:14:06 | 只看該作者
Adjuvant Therapy of Renal Cell Carcinoma,ed studies available do not demonstrate an advantage for pre- or postoperative therapy. Patient selection criteria have varied, but generally high risk groups with T. tumors and lymph node metastases (N.) disease have been included. In the future, adjuvant trials conducted in this group of patients
57#
發(fā)表于 2025-3-31 12:04:58 | 只看該作者
58#
發(fā)表于 2025-3-31 16:56:26 | 只看該作者
Active Surveillance of Localized Renal Tumors,l body imaging. Active surveillance of these lesions has been pursued in elderly or infirm patients. Here we review the current data regarding the growth kinetics, pathology, stage progression, and clinical management of renal masses under active surveillance. The limitations of these data are discussed.
59#
發(fā)表于 2025-3-31 20:04:46 | 只看該作者
The Role of Angioinfarction in the Management of Renal Tumors,ogenesis pathways by eliminating the tumor’s blood supply. Angioinfarction of renal tumors may be used to both the surgeon’s and patient’s advantage. Here we review the history, indications, techniques, and complications of angioinfarction in the management of primary renal tumors and their metastases.
60#
發(fā)表于 2025-3-31 22:13:01 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-25 13:33
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
南通市| 乐至县| 海口市| 凤城市| 佳木斯市| 四川省| 剑河县| 永胜县| 河源市| 青冈县| 永福县| 丰城市| 松桃| 麻江县| 绥棱县| 徐闻县| 教育| 岗巴县| 长泰县| 泰和县| 澄城县| 开原市| 平远县| 九寨沟县| 富锦市| 黔西县| 兴安盟| 福鼎市| 望谟县| 绥江县| 灵石县| 烟台市| 宁乡县| 沙田区| 孝义市| 资溪县| 玉山县| 海宁市| 南安市| 铜鼓县| 池州市|